These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23115539)

  • 21. Hydrogen profiles of dobutamine hydrochloride and fentanyl citrate solutions according to intravenous administration systems, temperature, and luminosity conditions.
    Barros DP; Fonseca FL; Pedreira Mda L; Peterlini MA
    J Infus Nurs; 2014; 37(5):362-8. PubMed ID: 25191819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physical compatibility of Normosol-R with critical care medications used in patients with COVID-19 during simulated Y-site administration.
    Holyk AA; Lindner AH; Lindner SE; Shippert BW
    Am J Health Syst Pharm; 2022 Jan; 79(1):e27-e33. PubMed ID: 34390244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Y-Site Compatibility of Intravenous Levetiracetam With Commonly Used Critical Care Medications.
    Lee TM; Villareal CL; Meyer LM
    Hosp Pharm; 2021 Aug; 56(4):282-286. PubMed ID: 34381262
    [No Abstract]   [Full Text] [Related]  

  • 24. Physical compatibility of lipid emulsions and intravenous medications used in neonatal intensive care settings.
    Senarathna SMDKG; Strunk T; Petrovski M; Woodland S; Martinez J; Chuang VTG; Batty KT
    Eur J Hosp Pharm; 2023 Oct; ():. PubMed ID: 37875283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical Compatibility of Sodium Glycerophosphate and Calcium Gluconate in Pediatric Parenteral Nutrition Solutions.
    MacKay M; Anderson C
    JPEN J Parenter Enteral Nutr; 2015 Aug; 39(6):725-8. PubMed ID: 24696096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compatibility of Vancomycin and Oxacillin During Simulated Y-Site Delivery.
    Teibel HM; Knoderer CA; Nichols KR
    Hosp Pharm; 2015 Sep; 50(8):710-3. PubMed ID: 26823620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physical compatibility of pentoxifylline and intravenous medications.
    Senarathna SMDKG; Strunk T; Petrovski M; Batty KT
    Arch Dis Child; 2019 Mar; 104(3):292-295. PubMed ID: 30472662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability and activity of intravenous immunoglobulin with neonatal dextrose and total parenteral nutrient solutions.
    Lindsay CA; Dang K; Adams JM; Ou CN; Baker CJ
    Ann Pharmacother; 1994 Sep; 28(9):1014-7. PubMed ID: 7803872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical and chemical compatibility of injectable acetaminophen during simulated y-site administration.
    Anderson C; Boehme S; Ouellette J; Stidham C; Mackay M
    Hosp Pharm; 2014 Jan; 49(1):42-7. PubMed ID: 24421562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compatibility of pentoxifylline and parenteral medications.
    Campbell AL; Petrovski M; Senarathna SG; Mukadam N; Strunk T; Batty KT
    Arch Dis Child; 2020 Apr; 105(4):395-397. PubMed ID: 31871042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection.
    Hanifah S; Nugroho B; Chabib L
    Anaesthesiol Intensive Ther; 2020; 52(1):23-27. PubMed ID: 32024349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the physical compatibility of injectable enrofloxacin with commonly used intravenous fluids and drugs during simulated Y-port administration.
    Aghili A; Thomovsky EJ; Johnson PA; Brooks AC; Pierce TJ; Gochenauer AE
    Am J Vet Res; 2021 May; 82(5):358-366. PubMed ID: 33904804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability of midazolam hydrochloride in parenteral nutrient solutions.
    Bhatt-Mehta V; Rosen DA; King RS; Maksym CJ
    Am J Hosp Pharm; 1993 Feb; 50(2):285-8. PubMed ID: 8480785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical Compatibility of Ibuprofen Lysine Injection with Selected Drugs During Simulated Y-site Injection.
    Holt RJ; Siegert SW; Krishna A
    J Pediatr Pharmacol Ther; 2008 Jul; 13(3):156-61. PubMed ID: 23055876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration.
    Fox LM; Wilder AG; Foushee JA
    Am J Health Syst Pharm; 2013 Mar; 70(6):520-4. PubMed ID: 23456406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term compatibility of furosemide with crystalloid solutions.
    Adin DB; Hill RC; Scott KC
    J Vet Intern Med; 2003; 17(5):724-6. PubMed ID: 14529143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Y-site Incompatibility Between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story?
    Kufel WD; Miller CD; Johnson PR; Reid K; Zahra JJ; Seabury RW
    Hosp Pharm; 2017 Feb; 52(2):132-137. PubMed ID: 28321140
    [No Abstract]   [Full Text] [Related]  

  • 38. [Physical compatibility of sodium bicarbonate with other drugs often administered in the intensive care unit].
    Ribas Nicolau B; Pérez Juan E; Amorós Cerdá SM; Arévalo Rubert MJ; Maqueda Palau M
    Enferm Intensiva; 2011; 22(2):78-82. PubMed ID: 21256788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of fosphenytoin sodium with intravenous solutions in glass bottles, polyvinyl chloride bags, and polypropylene syringes.
    Fischer JH; Cwik MJ; Luer MS; Sibley CB; Deyo KL
    Ann Pharmacother; 1997 May; 31(5):553-9. PubMed ID: 9161647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro compatibility studies of vancomycin with ready-to-use parenteral nutrition admixtures for safer clinical practice.
    Stawny M; Nadolna M; Jelińska A
    Clin Nutr; 2020 Aug; 39(8):2539-2546. PubMed ID: 31784302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.